A detailed history of Family Management Corp transactions in Bio Cardia, Inc. stock. As of the latest transaction made, Family Management Corp holds 77,500 shares of BCDA stock, worth $227,850. This represents 0.01% of its overall portfolio holdings.

Number of Shares
77,500
Previous 77,500 -0.0%
Holding current value
$227,850
Previous $51,000 39.22%
% of portfolio
0.01%
Previous 0.01%

Shares

5 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q1 2023

May 15, 2023

SELL
$1.87 - $2.54 $121,176 - $164,592
-64,800 Reduced 45.54%
77,500 $151,000
Q4 2022

Feb 14, 2023

BUY
$1.61 - $2.09 $183 - $238
114 Added 0.08%
142,300 $297,000
Q3 2022

Nov 14, 2022

BUY
$0.24 - $2.09 $34,124 - $297,168
142,186 New
142,186 $276,000
Q1 2022

May 16, 2022

SELL
N/A
-142,186 Closed
0 $0
Q3 2021

Nov 15, 2021

BUY
N/A
142,186 New
142,186 $446,000

Others Institutions Holding BCDA

About BioCardia, Inc.


  • Ticker BCDA
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 17,758,200
  • Market Cap $52.2M
  • Description
  • BioCardia, Inc., a clinical-stage regenerative medicine company, develops cellular and cell-derived therapeutics for cardiovascular and pulmonary diseases. Its lead therapeutic candidate is the CardiAMP Cell Therapy System for the treatment of heart failure and chronic myocardial ischemia; and allogeneic cell therapy for cardiac and pulmonary di...
More about BCDA
Track This Portfolio

Track Family Management Corp Portfolio

Follow Family Management Corp and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Family Management Corp, based on Form 13F filings with the SEC.

News

Stay updated on Family Management Corp with notifications on news.